PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 8400589-9 1993 Anabolic IGF-1 and insulin levels showed significant negative correlation with the catabolic indicators 3-methylhistidine and catecholamine excretion. 3-methylhistidine 104-121 insulin Homo sapiens 19-26 1710892-8 1991 Muscle protein breakdown, as assessed by 3-methylhistidine excretion, was inhibited by insulin, but not by the IGF peptides. 3-methylhistidine 41-58 insulin Homo sapiens 87-94 3086996-6 1986 These findings, along with the partial reduction in the excretion of 3-methylhistidine and nitrogen, suggest that insulin, in combination with infused calories and protein, decreases the loss of muscle protein after trauma. 3-methylhistidine 69-86 insulin Homo sapiens 114-121 3908486-4 1985 Changes in plasma 3-methyl-histidine (3-MeHis) were obtained as an independent qualitative indicator of insulin-mediated reduction in proteolysis. 3-methylhistidine 18-36 insulin Homo sapiens 104-111 3908486-4 1985 Changes in plasma 3-methyl-histidine (3-MeHis) were obtained as an independent qualitative indicator of insulin-mediated reduction in proteolysis. 3-methylhistidine 38-45 insulin Homo sapiens 104-111 7026404-2 1981 3-Methylhistidine excretion was increased in cirrhotics irrespective of the etiology of the disease, and correlated with basal glucagon levels and with the insulin/glucagon ratio. 3-methylhistidine 0-17 insulin Homo sapiens 156-163 7173522-5 1982 Improved glycaemic control reduced 3-methylhistidine excretion in both insulin-dependent and non-insulin-dependent diabetes. 3-methylhistidine 35-52 insulin Homo sapiens 71-78 7043169-3 1982 When the insulin dose of the diabetic subject was reduced by 15% or 25%, the concentrations of blood and urinary glucose were significantly increased by the rate of urinary 3-methylhistidine excretion was not increased further. 3-methylhistidine 173-190 insulin Homo sapiens 9-16 7026404-3 1981 In nine cirrhotics and nine age- and sex-matched controls, similar correlations were found between 3-methylhistidine and the areas under 24-hr glucagon or insulin/glucagon curves. 3-methylhistidine 99-116 insulin Homo sapiens 155-162 7026404-4 1981 A larger amount of 3-methylhistidine was excreted during the nighttime than during the daytime, when glucagon secretion was suppressed and the insulin/glucagon ratio was increased. 3-methylhistidine 19-36 insulin Homo sapiens 143-150 23697717-8 2013 Fasting insulin was related with 3-methylhistidine, Asparagine, Alanine, gamma-aminobutyric acid and Cystathionine. 3-methylhistidine 33-50 insulin Homo sapiens 8-15